GiT Updates and More
Kanalga Telegramβda oβtish
Gi doctor with interests in endoscopy, gut health, liver & medicine in general.
Ko'proq ko'rsatish5 318
Obunachilar
+124 soatlar
+277 kun
+9530 kun
Postlar arxiv
5 318
A novel approach to achieve deep remission in dupilumab-refractory EoE:
Dupilumab plus exclusive palatable elemental diet for two weeks led to sustained symptomatic and normalization of esophageal distensibility
#ACG2025
5 318
Balancing Act: Managing Active Bleeding and Risk of Thrombosis in the Hospital.
#ACG2025
PDF π
5 318
Acute Severe Ulcerative Colitis Optimizing Inpatient Management for Improved Outcomes.
#ACG2025
PDF π
5 318
Managing Cirrhosis and Its Complications: Inpatient Strategies for Optimal Care.
#ACG2025
PDF π
5 318
Diverticular Disease: Unpacking the Pockets of Mystery and Navigating Effective Management.
#ACG2025
PDF π
5 318
In patients with gastroparesis undergoing G-POEM, having repeated past botox injections is associated with longer procedural times. Probably due to fibrosis.
#ACG2025
5 318
G-POEM is gaining popularity compared to gastric electrical stimulation for gastroparesis, in particular in younger patients.
#ACG2025
5 318
π Patients with FD/ gastroparesis carry a substantially greater and earlier burden compared to those with IBS.
π IBS has been known to be associated with psychological symptoms.
5 318
β οΈPSC in 2025: no approved drugs, heterogeneous course & shaky endpoints.
Hepatology review
5 318
Review: Medical treatment of primary sclerosing cholangitis: What have we learned and where are we going?
PDF π
AASLD Hepatology 82(4):p 927-948, October 2025.
5 318
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update.
PDF π
Journal of Hepatology 26 October 2025
5 318
Besting Barrett's: Advances in the Diagnosis and Treatment of Barrett's Esophagus .
#ACG2025
PDFπ
